The Motley Fool

These 2 FTSE 250 stocks are rising despite the crash. Here’s what I’d do now

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A bull outlined against a field
Image source: Getty Images.

Once again, stock markets are crashing over renewed coronavirus fears, but these two FTSE 250 stocks have defied the downturn to post double-digit growth over the past week. So is now the time to buy them?

FTSE 250-listed animal genetics company Genus (LSE: GNS) is up more than 15% over the last turbulent week, and 60% over 12 months. Its 10-year growth chart shows a steady upward climb that even the coronavirus hasn’t interrupted.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Sheer Genus

The Genus share price was given a further lift last week as its interims boasted a “strong first-half performance and strategic momentum”, with record adjusted profit before tax, up 27% in constant currency to £36.6m. It also posted its highest first-half adjusted profit before tax growth rate in more in a decade.

Genus aims to breed better pigs and cattle for farmers, allowing them to produce high quality meat and milk more efficiently and sustainably. It has benefited from strong demand from China, which has been restocking following the spread of African Swine Fever, but is also growing strongly in Europe, Latin America, and North America.

CEO Stephen Wilson warned that COVID-19 uncertainties could disrupt trade and hit the business, but added that the board’s second-half expectations should still be met.

Genus looks like a business with strong growth potential to me, as the global population rises and emerging economies expect meat-rich diets. The downside is that it is expensive, trading at a whopping 40.1 times forecast earnings. Those earnings are forecast to grow 13% next year, but it can’t afford any slippage given today’s valuation. It could fly higher if China enjoys a V-shaped recovery in the weeks ahead. Definitely one for a watchlist.

On the PLUS side

Plus500 (LSE: PLUS) is an investment platform that specialises in contracts for difference (CFDs), a popular form of derivative that let traders play shares, forex, commodities, cryptocurrencies, ETFs, options and indices. Demand rises when markets are volatile, as investors look to play falling share prices, boosting customer activity (and fees).

The Plus500 share price is up 10% in the last week, and 120% over three years, but with plenty of volatility in-between. Its shares crashed a year ago, after management warned of “materially lower” profits due to stricter EU limits on how much retail traders can borrow from their broker.

By May, the yield had shot up to 16%, while it was trading at just seven times forecast earnings. Many shied away, but crypto-currency Bitcoin’s resurgence gave it a lift, with further support from recent virus volatility.

My fellow writers on the Fool are sceptical about this stock, as its fortunes are prone to market hype, and customer churn is high. However, last week’s trading update reported “a significant increase in levels of customer trading activity”, with the current quarter up “substantially” year-on-year.

Trading at 10 times forward earnings and with a forecast yield of 4.6%, Plus500 looks tempting, but only for risk seekers who do their research. In contrast to Genus, Plus500 could take a hit from a V-shaped recovery.

One Killer Stock For The Cybersecurity Surge

Cybersecurity is surging, with experts predicting that the cybersecurity market will reach US$366 billion by 2028more than double what it is today!

And with that kind of growth, this North American company stands to be the biggest winner.

Because their patented “self-repairing” technology is changing the cybersecurity landscape as we know it…

We think it has the potential to become the next famous tech success story.

In fact, we think it could become as big… or even BIGGER than Shopify.

Click here to see how you can uncover the name of this North American stock that’s taking over Silicon Valley, one device at a time…

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.